Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational study

被引:13
作者
Giugliano, Francesca Paola [1 ]
Strisciuglio, Caterina [1 ,2 ]
Martinelli, Massimo [1 ]
Andreozzi, Marialuisa [1 ]
Cenni, Sabrina [1 ]
Campione, Severo [3 ]
D'Armiento, Maria [3 ]
Staiano, Annamaria [1 ]
Miele, Erasmo [1 ]
机构
[1] Univ Naples Federico II, Sect Pediat, Dept Translat & Med Sci, Via S Pansini 5, I-80131 Naples, Italy
[2] Univ Naples 2, Dept Woman Child & Gen Specialized Surg, Naples, Italy
[3] Univ Naples Federico II, Sect Pathol, Dept Biomorphol & Funct Sci, Naples, Italy
关键词
Children; IBD; Mucosal healing; Thiopurines; EVIDENCE-BASED CONSENSUS; ULCERATIVE-COLITIS; CROHNS-DISEASE; FECAL CALPROTECTIN; ACTIVITY INDEX; 5-AMINOSALICYLIC ACID; REMISSION; THERAPY; MANAGEMENT; CHILDREN;
D O I
10.1016/j.dld.2017.10.017
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The new concept of disease remission for pediatric inflammatory bowel diseases (IBD) implies the achievement of mucosal healing. Aims: We aimed to evaluate endoscopic and histologic healing in children with Ulcerative Colitis (UC) and Crohn's disease (CD) in clinical remission after 52 weeks of Azathioprine. Methods: From December 2012 to July 2015 we prospectively enrolled IBD children starting Azathioprine. Enrolled patients in clinical remission underwent colonoscopy after 52 weeks. Macroscopic assessment was described with Mayo score and the simplified endoscopic score for UC and CD, respectively. For microscopic assessment, an average histology score was used. Data on inflammatory markers and fecal calprotectin were also collected. Results: Fourty-seven patients were included in the analysis. Endoscopic healing was detected in 20/26 (76.9%) UC children and 10/21 (47.6%) CD patients. Median Mayo score and simplified endoscopic score were significantly decreased at week 52 (p < 0.001; p = 0.005). Median average histology score was not significantly different at week 52 in both diseases. Fecal calprotectin was directly correlated with simplified endoscopic score (T0: r = 0.4, p = 0.05; T52: r = 0.5, p = 0.01), but not with Mayo score. No correlation was found between endoscopic and histologic scores. Conclusions: IBD children under Azathioprine reach endoscopic healing, but not histological remission. (c) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:240 / 246
页数:7
相关论文
共 39 条
[1]   Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease [J].
Aomatsu, Tomoki ;
Yoden, Atsushi ;
Matsumoto, Kyoichi ;
Kimura, Emi ;
Inoue, Keisuke ;
Andoh, Akira ;
Tamai, Hiroshi .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) :2372-2377
[2]   Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis [J].
Ardizzone, S ;
Maconi, G ;
Russo, A ;
Imbesi, V ;
Colombo, E ;
Porro, GB .
GUT, 2006, 55 (01) :47-53
[3]   Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis [J].
Bitton, A ;
Peppercorn, MA ;
Antonioli, DA ;
Niles, JL ;
Shah, S ;
Bousvaros, A ;
Ransil, B ;
Wild, G ;
Cohen, A ;
Edwardes, MDD ;
Stevens, AC .
GASTROENTEROLOGY, 2001, 120 (01) :13-20
[4]   Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative [J].
Bryant, R. V. ;
Winer, S. ;
Travis, S. P. L. ;
Riddell, R. H. .
JOURNAL OF CROHNS & COLITIS, 2014, 8 (12) :1582-1597
[5]   Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis [J].
Colombel, Jean Frederic ;
Rutgeerts, Paul ;
Reinisch, Walter ;
Esser, Dirk ;
Wang, Yanxin ;
Lang, Yinghua ;
Marano, Colleen W. ;
Strauss, Richard ;
Oddens, Bjoern J. ;
Feagan, Brian G. ;
Hanauer, Stephen B. ;
Lichtenstein, Gary R. ;
Present, Daniel ;
Sands, Bruce E. ;
Sandborn, William J. .
GASTROENTEROLOGY, 2011, 141 (04) :1194-1201
[6]   Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease. [J].
Colombel, Jean Frederic ;
Sandborn, William J. ;
Reinisch, Walter ;
Mantzaris, Gerassimos J. ;
Kornbluth, Asher ;
Rachmilewitz, Daniel ;
Lichtiger, Simon ;
D'Haens, Geert ;
Diamond, Robert H. ;
Broussard, Delma L. ;
Tang, Kezhen L. ;
van der Woude, C. Janneke ;
Rutgeerts, Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (15) :1383-1395
[7]   Adalimumab Induces Deep Remission in Patients With Crohn's Disease [J].
Colombel, Jean-Frederic ;
Rutgeerts, Paul J. ;
Sandborn, William J. ;
Yang, Mei ;
Camez, Anne ;
Pollack, Paul F. ;
Thakkar, Roopal B. ;
Robinson, Anne M. ;
Chen, Naijun ;
Mulani, Parvez M. ;
Chao, Jingdong .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (03) :414-+
[8]   Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine [J].
D'Haens, G ;
Geboes, K ;
Rutgeerts, P .
GASTROINTESTINAL ENDOSCOPY, 1999, 50 (05) :667-671
[9]  
d'Haens G R., Gastroenterology
[10]   A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis [J].
D'Haens, Geert ;
Sandborn, William J. ;
Feagan, Brian G. ;
Geboes, Karel ;
Hanauer, Stephen B. ;
Irvine, E. Jan ;
Lemann, Marc ;
Marteau, Philippe ;
Rutgeerts, Paul ;
Scholmerich, Jurgen ;
Sutherland, Lloyd R. .
GASTROENTEROLOGY, 2007, 132 (02) :763-786